Anhui Huangshan Capsule Résultats passés
Passé contrôle des critères 2/6
Anhui Huangshan Capsule has been growing earnings at an average annual rate of 9.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.2% per year. Anhui Huangshan Capsule's return on equity is 5.6%, and it has net margins of 11.1%.
Informations clés
9.7%
Taux de croissance des bénéfices
9.7%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.1% |
| Taux de croissance des recettes | 9.2% |
| Rendement des fonds propres | 5.6% |
| Marge nette | 11.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Anhui Huangshan Capsule Co., Ltd. (SZSE:002817) Investors Are Less Pessimistic Than Expected
Sep 30
Anhui Huangshan Capsule's (SZSE:002817) Shareholders Have More To Worry About Than Only Soft Earnings
Aug 28Returns On Capital Are Showing Encouraging Signs At Anhui Huangshan Capsule (SZSE:002817)
Jun 06Anhui Huangshan Capsule Co., Ltd.'s (SZSE:002817) 26% Price Boost Is Out Of Tune With Earnings
Mar 08Ventilation des recettes et des dépenses
Comment Anhui Huangshan Capsule gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 454 | 50 | 59 | 15 |
| 30 Jun 24 | 442 | 57 | 55 | 14 |
| 31 Mar 24 | 438 | 60 | 59 | 15 |
| 31 Dec 23 | 463 | 65 | 62 | 16 |
| 30 Sep 23 | 483 | 68 | 62 | 15 |
| 30 Jun 23 | 476 | 67 | 64 | 16 |
| 31 Mar 23 | 470 | 67 | 57 | 16 |
| 01 Jan 23 | 428 | 61 | 55 | 15 |
| 30 Sep 22 | 403 | 62 | 54 | 13 |
| 30 Jun 22 | 392 | 62 | 55 | 14 |
| 31 Mar 22 | 377 | 60 | 57 | 14 |
| 31 Dec 21 | 380 | 57 | 59 | 13 |
| 30 Sep 21 | 382 | 54 | 52 | 14 |
| 30 Jun 21 | 372 | 53 | 55 | 12 |
| 31 Mar 21 | 353 | 47 | 57 | 10 |
| 31 Dec 20 | 319 | 45 | 57 | 9 |
| 30 Sep 20 | 304 | 41 | 74 | 10 |
| 30 Jun 20 | 312 | 40 | 74 | 11 |
| 31 Mar 20 | 318 | 39 | 76 | 12 |
| 31 Dec 19 | 326 | 39 | 74 | 13 |
| 30 Sep 19 | 320 | 39 | 64 | 16 |
| 30 Jun 19 | 305 | 34 | 59 | 18 |
| 31 Mar 19 | 297 | 34 | 57 | 15 |
| 31 Dec 18 | 295 | 36 | 57 | 13 |
| 30 Sep 18 | 286 | 37 | 56 | 8 |
| 30 Jun 18 | 284 | 40 | 51 | 12 |
| 31 Mar 18 | 285 | 44 | 49 | 12 |
| 31 Dec 17 | 286 | 46 | 51 | 10 |
| 30 Sep 17 | 289 | 47 | 56 | 9 |
| 30 Jun 17 | 290 | 47 | 64 | 0 |
| 31 Mar 17 | 290 | 50 | 63 | 0 |
| 31 Dec 16 | 283 | 52 | 60 | 0 |
| 31 Dec 15 | 254 | 55 | 49 | 0 |
| 31 Dec 14 | 273 | 52 | 50 | 0 |
| 31 Dec 13 | 269 | 48 | 51 | 0 |
Des revenus de qualité: 002817 has high quality earnings.
Augmentation de la marge bénéficiaire: 002817's current net profit margins (11.1%) are lower than last year (14.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 002817's earnings have grown by 9.7% per year over the past 5 years.
Accélération de la croissance: 002817's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 002817 had negative earnings growth (-25.9%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement des fonds propres
ROE élevé: 002817's Return on Equity (5.6%) is considered low.